Skip to main content

Advertisement

Log in

Is the prevalence of arterial hypertension in rheumatoid arthritis and osteoarthritis associated with disease?

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

In this study, we compare the prevalence of arterial hypertension (HT) in rheumatoid arthritis (RA) and osteoarthritis (OA) patients, exposed to high- and low-grade chronic inflammation, respectively, to assess the possible association between chronic inflammation and HT. A total of consecutive 627 RA and 352 OA patients were enrolled in this multicentric study. HT was defined as a systolic blood pressure (BP) ≥ 140 and/or diastolic BP ≥ 90 mmHg or current use of any antihypertensive drug. Overweight/obesity was defined as body mass index (BMI) ≥ 25, and patients ≥65 years were considered elderly. The prevalence of HT was higher in the OA group than in the RA group [73.3 % (95 % CI, 68.4, 77.7) and 59.5 % (95 % CI, 55.6, 68.4) P < 0.001, respectively]. When the results were adjusted for age and BMI, the HT prevalence was similar in both groups [RA 59 % (95 % CI, 55.1, 63.8) OA 60 % (95 % CI, 58.4, 65.0)]. In both groups, the prevalence of HT was higher in the elderly and those who were overweight than in the younger patients and those with a BMI < 25. Overweight (BMI ≥ 25) and age ≥65 were independent predictors of HT in multivariate logistic regression model, which showed no association between HT and the disease (RA or OA). The results indicate a robust association of age and BMI with HT prevalence in both RA and OA. The difference in HT prevalence between RA and OA is due rather to age and BMI than to the features of the disease, putting into question specific association of HT with RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. John H, Kitas G, Toms T, Goodson N (2009) Cardiovascular co-morbidity in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 23:71–82

    Article  PubMed  Google Scholar 

  2. Serelis J, Panagiotakos DB, Mavrommati M, Skopouli FN (2011) Cardiovascular disease is related to hypertension in patients with rheumatoid arthritis: a Greek cohort study. J Rheumatol 38:236–241

    Article  PubMed  Google Scholar 

  3. Panoulas VF, Metsios GS, Pace AV et al (2008) Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 47:1286–1298

    Article  CAS  Google Scholar 

  4. Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A (2011) Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 78:179–183

    Article  PubMed  Google Scholar 

  5. Marks R, Allegrante JP (2002) Comorbid disease profiles of adults with end-stage hip osteoarthritis. Med Sci Monit 8:CR305-9

    Google Scholar 

  6. van Dijk GM, Veenhof C, Schellevis F et al (2008) Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord 9:95

    Article  PubMed  Google Scholar 

  7. Singh G, Miller JD, Lee FH, Pettitt D, Russell MW (2002) Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey. Am J Manag Care 8(15 Suppl):S383–S391

    PubMed  Google Scholar 

  8. Gabriel SE, Crowson CS, O’Fallon WM (1999) Comorbidity in arthritis. J Rheumatol 26:2475–2479

    PubMed  CAS  Google Scholar 

  9. Erb N, Pace AV, Douglas KMJ, Banks MJ, Kitas GD (2004) Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 33:293–299

    Article  PubMed  CAS  Google Scholar 

  10. Verdecchia P, Angeli F, Mazzotta G, Gentile G, Reboldi G (2010) Emerging therapeutic strategies in osteoarthritic patients with hypertension. In: Optimising the management of osteoarthritis: emerging therapies, London BMJ Group, pp 8–12

  11. Sipe JD (1995) Acute-phase proteins in osteoarthritis. Semin Arthritis Rheum 25:75–86

    Google Scholar 

  12. Morovic-Vergles J, Culo MI, Gamulin S, Culo F (2008) Cyclic adenosine 5′-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients. Rheumatol Int 29:167–171

    Article  PubMed  CAS  Google Scholar 

  13. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  PubMed  CAS  Google Scholar 

  14. Altman R, Alarcon G, Appelrouth D, Bloch D et al (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505–514

    Article  PubMed  CAS  Google Scholar 

  15. Altman R, Alarcon G, Appelrouth D, Bloch D et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601–1610

    Article  PubMed  CAS  Google Scholar 

  16. Altman R, Asch E, Bloch D et al (1986) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum 29:1039–1049

    Article  PubMed  CAS  Google Scholar 

  17. Panoulas VF, Douglas KMJ, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD et al (2007) Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology 46:1477–1482

    Article  PubMed  CAS  Google Scholar 

  18. Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28:1462–1536

    PubMed  Google Scholar 

  19. See R, Abdullah SM, McGuire DK et al (2007) The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study. J Am Coll Cardiol 50:752–759

    Article  PubMed  Google Scholar 

  20. Mannion AF, Balagué F, Pellisé F, Cedraschi C (2007) Pain measurement in patients with low back pain. Nat Clin Pract Rheumatol 3:610–618

    Article  PubMed  Google Scholar 

  21. DAS-score. nl: Disease activity score in rheumatic arthritis: http://www.das-score.nl/. Accessed 21 March 2011

  22. Kirwan JR, Reeback JS (1986) Stanford health assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 25:206–209

    Article  PubMed  CAS  Google Scholar 

  23. The DAS calculator: http://www.das-score.nl/dasculators.html. Accessed 21 March 2011

  24. World Health Organization. Department of Noncommunicable Disease Surveillance (1999) Definition and diagnostic criteria for diabetes mellitus and other categories of glucose intolerance. In: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva, pp 2–8

  25. Zhang J, Yu KF (1998) What’s the relative risk? JAMA 280:1690–1691

    Article  PubMed  CAS  Google Scholar 

  26. Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81:646–656

    PubMed  Google Scholar 

  27. Wolf-Maier K, Cooper RS, Banegas JR et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363–2369

    Article  PubMed  Google Scholar 

  28. Aneja A, El-Atat F, McFarlane SI, Sowers JR (2004) Hypertension and obesity. Recent Prog Horm Res 59:169–205

    Article  PubMed  CAS  Google Scholar 

  29. Erceg M, Hrabak-Zerjavić V, Ivicević Uhernik A (2007) Regional characteristics of arterial hypertension in adult population of Croatia. Acta Med Croatica 61:293–298 (Croatian)

  30. Dessein PH, Norton GR (2008) Should patients with RA be aggressively monitored for hypertension? Nat Clin Pract Rheumatol 4:18–19

    Article  PubMed  Google Scholar 

  31. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y et al (2007) Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis 66:1316–1321

    Article  PubMed  Google Scholar 

  32. Panoulas VF, Douglas KM, Stavropoulos-Kalinoglou A et al (2008) Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology 47:72–75

    Article  PubMed  CAS  Google Scholar 

  33. Fernández-Real JM, Ricart W (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278–301

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Professor Davor Eterovic, Ph.D., of the University of Split Medical School for statistical advice. This work was supported by a grant from the Ministry of Science, Education and Sport, the Republic of Croatia (198-1081874-0183 to JMV).

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jadranka Morović-Vergles.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 176 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morović-Vergles, J., Šalamon, L., Marasović-Krstulović, D. et al. Is the prevalence of arterial hypertension in rheumatoid arthritis and osteoarthritis associated with disease?. Rheumatol Int 33, 1185–1192 (2013). https://doi.org/10.1007/s00296-012-2522-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2522-1

Keywords

Navigation